BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6261351)

  • 21. [Treatment of elderly patients with acute myeloid leukemia].
    Löwenberg B
    Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2157-9. PubMed ID: 9550795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative treatment of acute leukemia in adults].
    Kubel M; Helbig W; Schultze W; Günther C; Schwenke H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(4):559-73. PubMed ID: 6162725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
    Malagola M; Peli A; Damiani D; Candoni A; Tiribelli M; Martinelli G; Piccaluga PP; Paolini S; De Rosa F; Lauria F; Bocchia M; Gobbi M; Pierri I; Zaccaria A; Zuffa E; Mazza P; Priccolo G; Gugliotta L; Bonini A; Visani G; Skert C; Bergonzi C; Roccaro AM; Filì C; Fanin R; Baccarani M; Russo D
    Eur J Haematol; 2008 Nov; 81(5):354-63. PubMed ID: 18637030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The optimization of the infusion therapy procedure in patients with acute leukemias].
    Moiseev SI; Abdulkadyrov KM
    Ter Arkh; 1996; 68(10):41-4. PubMed ID: 9026941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of causes of death during intensive chemotherapy according to treatment protocol AML-BFM 93].
    Creutzig U; Zimmermann M; Reinhardt D; Lehrnbecher T
    Klin Padiatr; 2003; 215(3):151-8. PubMed ID: 12778355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current status of therapy and prognosis in acute adult leukemia].
    Gmür J
    Ther Umsch; 1996 Feb; 53(2):111-6. PubMed ID: 8629260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognostic importance of DNA histograms of bone marrow cells in acute myeloblastic leukemias].
    Janowska-Wieczorek A; Maj S; Apel D
    Acta Haematol Pol; 1981; 12(3-4):171-4. PubMed ID: 6952737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia].
    López A; Soler JA; Juliá A; Novo A; Bueno J
    Med Clin (Barc); 1994 Jan; 102(3):81-5. PubMed ID: 8133717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
    Dengler R; Plewan A; Münstermann U; Busch R; Eger G; Emmerich B
    Clin Cancer Res; 1995 Feb; 1(2):199-205. PubMed ID: 9815974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Infectious complications observed during the use of antimitotic agents in hematology].
    Schaison G; Weil M; Backes C; Jacquillat CL; Bussel A; Perol Y
    Sem Hop; 1976 Jan; 52(2):99-103. PubMed ID: 185705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fatal Aeromonas septicemia in two patients with acute myelogenous leukemia: clinical significance in neutropenic states and review of the literature].
    Kimura Y; Toki H; Okabe K
    Rinsho Ketsueki; 1987 Aug; 28(8):1419-23. PubMed ID: 3323564
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mixed infections with aerobic and anaerobic bacterial flora in children with granulocytopenia during antineoplastic therapy].
    Karwacki M; Lawrynowicz R; Ochocka M
    Pediatr Pol; 1988 Nov; 63(11):733-8. PubMed ID: 3253660
    [No Abstract]   [Full Text] [Related]  

  • 35. [How to be an administration schedule of antileukemic agents in the treatment of acute leukemia from the standpoint of leukemic cell kinetics (author's transl)].
    Shirakawa S
    Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):707-30. PubMed ID: 4533927
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the consolidation, maintenance and reconsolidation treatment of acute leukemia (author's transl)].
    Masaoka T
    Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):748-55. PubMed ID: 4533929
    [No Abstract]   [Full Text] [Related]  

  • 37. [Neurological complications of acute myeloid leukemia in adults].
    Pagano L; Marra R; De Stefano V; Di Donfrancesco A; Leone G
    Minerva Med; 1986 Jan; 77(1-2):13-7. PubMed ID: 3456091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection in acute myelogenous leukaemia. An analysis of 168 patients undergoing remission induction.
    Rohatiner AZ; Lowes JA; Lister TA
    J Hosp Infect; 1981 Jun; 2(2):135-43. PubMed ID: 6174576
    [No Abstract]   [Full Text] [Related]  

  • 39. Differentiation induction therapy of acute myelogenous leukaemias.
    Hassan HT
    Haematologia (Budap); 1988; 21(3):141-50. PubMed ID: 3053358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The chemotherapy of acute promyelocytic leukemia with a new antileukemic agent "neocarzinostatin" (author's transl)].
    Nagao T; Kamimura O; Fuchimoto T; Chen H; Toki H
    Rinsho Ketsueki; 1974 Sep; 15(9):1021-7. PubMed ID: 4530880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.